Contact Dr. Jaleel’s office at 919-684-1830 for more information on these studies:
Clinical Trial 1: Role of hormones in hidradenitis suppurativa and other skin diseases.
Hidradenitis Suppurativa (HS)
- Role of hormones in hidradenitis suppurativa and other skin diseases.
- Status: Enrolling participants
- PI: Dr. Tarannum Jaleel
- More Details
- Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository- HS PROGRESS
- Status: Enrolling participants
- PI: Dr. Tarannum Jaleel
- More Details
- Biorepository of Patients with Hidradenitis Suppurativa (HS): Determination of potential predictors and moderators of treatment response in patients with HS.
- Status: Enrolling participants
- PI: Dr. Tarannum Jaleel
- More Details
- A Study to Test the Long-term Treatment of Bimekizumab in Study Participants with Moderate to Severe Hidradenitis Suppurativa (BE HEARD EXT).
- Status: Open, not enrolling at this time
- PI: Dr. Tarannum Jaleel
- More Details
- A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS).
- Status: Enrolling participants
- PI: Dr. Tarannum Jaleel
- More Details
- A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa.
- Status: Open, not enrolling at this time
- PI: Dr. Tarannum Jaleel
- More Details